• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

股骨近端置换治疗非肿瘤性疾病的长期疗效

Long-term results of proximal femoral replacement for non-neoplastic disorders.

作者信息

Malkani A L, Settecerri J J, Sim F H, Chao E Y, Wallrichs S L

机构信息

Mayo Graduate School of Medicine, Rochester, Minnesota, USA.

出版信息

J Bone Joint Surg Br. 1995 May;77(3):351-6.

PMID:7744913
Abstract

We reviewed retrospectively 50 consecutive total hip arthroplasties with proximal femoral replacement prostheses in 49 patients. All the patients had massive bone loss. There were 31 women and 18 men who had undergone a mean of 3.1 hip operations. At the last review, 15 patients had died and two had been lost to follow-up, so that 32 patients (33 hips) were available for assessment. The mean age of the patients at the time of the operation was 60.6 years. The mean length of clinical follow-up was 11.1 +/- 4 years, and mean radiographic follow-up was 7.6 +/- 3.2 years. The average preoperative Harris hip score was 46 +/- 13 points, which improved to 80 +/- 10 points after one year and to 76 +/- 16 points at the latest follow-up. The most frequent complication was dislocation, which occurred in 11 hips. Four femoral components and seven acetabular prostheses were revised because of aseptic loosening. With revision at the end point, survivorship after total hip arthroplasty with a proximal femoral replacement prosthesis was predicted to be 64% at 12 years. Although our preliminary results of hip salvage with a proximal femoral replacement prosthesis were encouraging, a longer follow-up has shown a higher rate of failure.

摘要

我们回顾性分析了49例患者连续50例使用股骨近端置换假体的全髋关节置换术。所有患者均有大量骨质流失。其中31例女性和18例男性平均接受了3.1次髋关节手术。在最后一次随访时,15例患者死亡,2例失访,因此32例患者(33髋)可供评估。手术时患者的平均年龄为60.6岁。临床随访的平均时长为11.1±4年,影像学随访的平均时长为7.6±3.2年。术前Harris髋关节评分平均为46±13分,术后1年提高到80±10分,最近一次随访时为76±16分。最常见的并发症是脱位,11髋发生脱位。4个股骨组件和7个髋臼假体因无菌性松动而翻修。以翻修为终点,使用股骨近端置换假体的全髋关节置换术后12年的预计生存率为64%。尽管我们使用股骨近端置换假体挽救髋关节的初步结果令人鼓舞,但更长时间的随访显示失败率更高。

相似文献

1
Long-term results of proximal femoral replacement for non-neoplastic disorders.股骨近端置换治疗非肿瘤性疾病的长期疗效
J Bone Joint Surg Br. 1995 May;77(3):351-6.
2
The bone-vacuum cementing technique for the fixation of the stem in total hip arthroplasty.全髋关节置换术中用于固定柄的骨真空固定技术。
Chir Organi Mov. 2001 Apr-Jun;86(2):99-110.
3
Good survival of uncemented tapered stems for failed intertrochanteric osteotomy: a mean 16 year follow-up study in 45 patients.未骨水泥型锥形柄用于转子间截骨失败后的良好生存率:45例患者平均16年随访研究
Arch Orthop Trauma Surg. 2008 Oct;128(10):1081-5. doi: 10.1007/s00402-007-0444-2. Epub 2007 Sep 18.
4
Long-term results of the cementless porous-coated anatomic total hip prosthesis.非骨水泥型多孔涂层解剖型全髋关节假体的长期效果
J Bone Joint Surg Br. 2005 May;87(5):623-7. doi: 10.1302/0301-620X.87B5.15554.
5
The outcome of total hip replacement in obese and non-obese patients at 10- to 18-years.肥胖和非肥胖患者全髋关节置换术后10至18年的结果。
J Bone Joint Surg Br. 2006 Oct;88(10):1286-92. doi: 10.1302/0301-620X.88B10.17660.
6
Ten-year results of uncemented hip stems for failed intertrochanteric osteotomy.粗隆间截骨术失败后非骨水泥型髋关节柄的十年随访结果。
Arch Orthop Trauma Surg. 2005 Jun;125(5):304-9. doi: 10.1007/s00402-005-0800-z. Epub 2005 Mar 2.
7
Long-term survivorship of cemented all-polyethylene acetabular components in patients > 75 years of age.75岁以上患者中骨水泥型全聚乙烯髋臼组件的长期生存率。
J Arthroplasty. 2000 Jun;15(4):461-7. doi: 10.1054/arth.2000.4340.
8
[Long-term results of the Schenker cementless femoral component].[申克无骨水泥股骨假体的长期结果]
Acta Chir Orthop Traumatol Cech. 2004;71(2):93-100.
9
[Early aseptic loosening of the CF 30 femoral stem].[CF 30股骨柄早期无菌性松动]
Acta Chir Orthop Traumatol Cech. 2007 Feb;74(1):59-64.
10
[Long-term experience with the combined ARBOND hydroxyapatite coating in implant osteointegration].[联合使用ARBOND羟基磷灰石涂层在种植体骨整合方面的长期经验]
Acta Chir Orthop Traumatol Cech. 2009 Jun;76(3):172-8.

引用本文的文献

1
A comparison of dislocation risk between dual mobility and traditional constructs used in proximal femoral replacement.双动型与传统型股骨近端置换假体脱位风险的比较
J Orthop. 2024 Jul 17;59:36-40. doi: 10.1016/j.jor.2024.07.014. eCollection 2025 Jan.
2
Treatment of femoral bone loss in revision total hip arthroplasty: a clinical practice review.翻修全髋关节置换术中股骨骨缺损的治疗:临床实践综述
Ann Jt. 2024 Jan 15;9:4. doi: 10.21037/aoj-23-31. eCollection 2024.
3
Megaprosthesis use in Paprosky III/IV femoral defects in non-oncological patients: analysis of survival, clinical, and functional outcomes after an average follow-up of five years.
非肿瘤患者中使用大假体治疗Paprosky III/IV型股骨缺损:平均五年随访后的生存率、临床及功能结果分析
Eur J Orthop Surg Traumatol. 2024 Feb;34(2):1183-1192. doi: 10.1007/s00590-023-03783-9. Epub 2023 Nov 25.
4
The outcomes of proximal femur replacement with hemiarthroplasty after tumor resection in individuals with Parkinson's disease.帕金森病患者肿瘤切除术后行半髋关节置换术的股骨近端置换结果。
Front Surg. 2023 Oct 13;10:1279813. doi: 10.3389/fsurg.2023.1279813. eCollection 2023.
5
The major proximal femoral defects: megaprosthesis in non oncological patients - A case series.主要股骨近端缺损:非肿瘤患者的大假体置换——病例系列
Orthop Rev (Pavia). 2023 Jan 28;15:38432. doi: 10.52965/001c.38432. eCollection 2023.
6
Proximal femoral replacement using the direct anterior approach to the hip.经髋关节直接前入路行股骨近端置换术。
Oper Orthop Traumatol. 2022 Jun;34(3):218-230. doi: 10.1007/s00064-022-00770-x. Epub 2022 May 31.
7
Survivorship and clinical outcomes of proximal femoral replacement in non-neoplastic primary and revision total hip arthroplasty: a systematic review.非肿瘤性原发性和翻修全髋关节置换术中近端股骨置换的生存和临床结果:系统评价。
BMC Musculoskelet Disord. 2021 Nov 8;22(Suppl 2):933. doi: 10.1186/s12891-021-04711-w.
8
Megaendoprostheses in the management of malignant tumors of the lower extremities-risk factors for revision surgery.下肢恶性肿瘤的大型内置物-翻修手术的风险因素。
J Orthop Surg Res. 2021 Aug 18;16(1):508. doi: 10.1186/s13018-021-02654-5.
9
Proximal femoral reconstruction with modular megaprostheses in non-oncological patients.非肿瘤患者使用模块化大型假体进行股骨近端重建。
Int Orthop. 2021 Oct;45(10):2531-2542. doi: 10.1007/s00264-021-05080-8. Epub 2021 Jul 14.
10
Survival and outcomes of modular endoprosthetic reconstruction of the proximal femur for primary and non-primary bone tumors: Single institutional results.原发性和非原发性骨肿瘤股骨近端模块化内置假体重建的生存率和结果:单机构研究结果
J Orthop. 2021 May 7;25:145-150. doi: 10.1016/j.jor.2021.05.008. eCollection 2021 May-Jun.